Click for best price
Postpemic Era POC Molecular Diagnostics Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global POC Molecular Diagnostics Market Segment Research Report 2022?, which aims to sort out the development status and trends of the POC Molecular Diagnostics industry at home and abroad, estimate the overall market scale of the POC Molecular Diagnostics industry and the market share of major countries, POC Molecular Diagnostics industry, and study and judge the downstream market demand of POC Molecular Diagnostics through systematic research, Analyze the competition pattern of POC Molecular Diagnostics, so as to help solve the pain points of various stakeholders in POC Molecular Diagnostics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of POC Molecular Diagnostics Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in POC Molecular Diagnostics Market?
Abbott
bioMerieux
Danaher
BD
Certest Biotec
F. Hoffmann-La Roche
NeoGenomics
Bionano Genomics
ExcitePCR
Micronics
Nimagen
Novigenix
Merck
Major Type of POC Molecular Diagnostics Covered in XYZResearch report:
Infectious Diseases
Oncology
Hematology and Endocrinology
Application Segments Covered in XYZResearch Market
Hospitals and Clinics
Research Institutes
Diagnostic Laboratories
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global POC Molecular Diagnostics Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
90 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global POC Molecular Diagnostics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global POC Molecular Diagnostics Market by Value
2.2.1 Global POC Molecular Diagnostics Revenue by Type
2.2.2 Global POC Molecular Diagnostics Market by Value
2.3 Global POC Molecular Diagnostics Market by Sales
2.3.1 Global POC Molecular Diagnostics Sales by Type
2.3.2 Global POC Molecular Diagnostics Market by Sales
3. The Major Driver of POC Molecular Diagnostics Industry
3.1 Historical & Forecast Global POC Molecular Diagnostics Sales and Revenue (2018-2028)
3.2 Largest Application for POC Molecular Diagnostics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional POC Molecular Diagnostics Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of POC Molecular Diagnostics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US POC Molecular Diagnostics Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe POC Molecular Diagnostics Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China POC Molecular Diagnostics Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan POC Molecular Diagnostics Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India POC Molecular Diagnostics Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea POC Molecular Diagnostics Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia POC Molecular Diagnostics Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America POC Molecular Diagnostics Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global POC Molecular Diagnostics Average Price Trend
13.1 Market Price for Each Type of POC Molecular Diagnostics in US (2018-2022)
13.2 Market Price for Each Type of POC Molecular Diagnostics in Europe (2018-2022)
13.3 Market Price for Each Type of POC Molecular Diagnostics in China (2018-2022)
13.4 Market Price for Each Type of POC Molecular Diagnostics in Japan (2018-2022)
13.5 Market Price for Each Type of POC Molecular Diagnostics in India (2018-2022)
13.6 Market Price for Each Type of POC Molecular Diagnostics in Korea (2018-2022)
13.7 Market Price for Each Type of POC Molecular Diagnostics in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of POC Molecular Diagnostics in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 POC Molecular Diagnostics Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of POC Molecular Diagnostics
15. POC Molecular Diagnostics Competitive Landscape
15.1 Abbott
15.1.1 Abbott Company Profiles
15.1.2 Abbott Product Introduction
15.1.3 Abbott POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 bioMerieux
15.2.1 bioMerieux Company Profiles
15.2.2 bioMerieux Product Introduction
15.2.3 bioMerieux POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Danaher
15.3.1 Danaher Company Profiles
15.3.2 Danaher Product Introduction
15.3.3 Danaher POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 BD
15.4.1 BD Company Profiles
15.4.2 BD Product Introduction
15.4.3 BD POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Certest Biotec
15.5.1 Certest Biotec Company Profiles
15.5.2 Certest Biotec Product Introduction
15.5.3 Certest Biotec POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 F. Hoffmann-La Roche
15.6.1 F. Hoffmann-La Roche Company Profiles
15.6.2 F. Hoffmann-La Roche Product Introduction
15.6.3 F. Hoffmann-La Roche POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 NeoGenomics
15.7.1 NeoGenomics Company Profiles
15.7.2 NeoGenomics Product Introduction
15.7.3 NeoGenomics POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Bionano Genomics
15.8.1 Bionano Genomics Company Profiles
15.8.2 Bionano Genomics Product Introduction
15.8.3 Bionano Genomics POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 ExcitePCR
15.9.1 ExcitePCR Company Profiles
15.9.2 ExcitePCR Product Introduction
15.9.3 ExcitePCR POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Micronics
15.10.1 Micronics Company Profiles
15.10.2 Micronics Product Introduction
15.10.3 Micronics POC Molecular Diagnostics Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Nimagen
15.12 Novigenix
15.13 Merck
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of POC Molecular Diagnostics Industry (Volume)
Figure 2. POC Molecular Diagnostics Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by POC Molecular Diagnostics Revenue in 2022
Figure 5. US POC Molecular Diagnostics Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe POC Molecular Diagnostics Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China POC Molecular Diagnostics Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan POC Molecular Diagnostics Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India POC Molecular Diagnostics Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea POC Molecular Diagnostics Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia POC Molecular Diagnostics Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. POC Molecular Diagnostics Revenue, by Type (Million USD) (2018-2028)
Table 4. POC Molecular Diagnostics Sales, by Type (K Unit) (2018-2028)
Table 5. POC Molecular Diagnostics Sales (K Unit) by Application (2018-2028)
Table 6. POC Molecular Diagnostics Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top POC Molecular Diagnostics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia POC Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of POC Molecular Diagnostics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott POC Molecular Diagnostics Product Introduction
Table 62. Abbott POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. bioMerieux Profiles
Table 65. bioMerieux POC Molecular Diagnostics Product Introduction
Table 66. bioMerieux POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. bioMerieux Strategic initiatives
Table 68. Danaher Profiles
Table 69. Danaher POC Molecular Diagnostics Product Introduction
Table 70. Danaher POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Danaher Strategic initiatives
Table 72. BD Profiles
Table 73. BD POC Molecular Diagnostics Product Introduction
Table 74. BD POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. BD Strategic initiatives
Table 76. Certest Biotec Profiles
Table 77. Certest Biotec POC Molecular Diagnostics Product Introduction
Table 78. Certest Biotec POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Certest Biotec Strategic initiatives
Table 80. F. Hoffmann-La Roche Profiles
Table 81. F. Hoffmann-La Roche POC Molecular Diagnostics Product Introduction
Table 82. F. Hoffmann-La Roche POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. F. Hoffmann-La Roche Strategic initiatives
Table 84. NeoGenomics Profiles
Table 85. NeoGenomics POC Molecular Diagnostics Product Introduction
Table 86. NeoGenomics POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. NeoGenomics Strategic initiatives
Table 88. Bionano Genomics Profiles
Table 89. Bionano Genomics POC Molecular Diagnostics Product Introduction
Table 90. Bionano Genomics POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Bionano Genomics Strategic initiatives
Table 92. ExcitePCR Profiles
Table 93. ExcitePCR POC Molecular Diagnostics Product Introduction
Table 94. ExcitePCR POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. ExcitePCR Strategic initiatives
Table 97. Micronics Profiles
Table 98. Micronics POC Molecular Diagnostics Product Introduction
Table 99. Micronics POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Micronics Strategic initiatives
Table 101. Nimagen Profiles
Table 102. Nimagen POC Molecular Diagnostics Product Introduction
Table 103. Nimagen POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Nimagen Strategic initiatives
Table 105. Novigenix Profiles
Table 106. Novigenix POC Molecular Diagnostics Product Introduction
Table 107. Novigenix POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Novigenix Strategic initiatives
Table 109. Merck Profiles
Table 110. Merck POC Molecular Diagnostics Product Introduction
Table 111. Merck POC Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Merck Strategic initiatives
